Boehringer Ingelheim has implemented single-use biomanufacturing at its mammalian facilities worldwide. The system can incorporate different commercially available single-use systems in 100L and 500L GMP facilities for clinical material supplies or for non-GMP process development.
Biopharmaceutical Business Review
Tuesday 11 September 2012
Boehringer Ingelheim implements disposable biomanufacturing
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment